WindRose Health Investors has announced it completed the sale of BPD Healthcare to MJH Life Sciences.

BPD, founded in 2002 and based in Boca Raton, Florida, is a healthcare marketing services firm.

WindRose, founded in 2000 and based in New York, pursues equity investments in healthcare companies. The firm invests in a broad range of industry segments, including outsourced services to payors and health systems, technology-enabled services, healthcare providers and value-added distribution.

MJH, founded in 1988 and based in Monroe, New Jersey, is a medical media company.

Terms of the transaction were not disclosed.

TPG and Blackstone will acquire Hologic, according to a news release. The deal is valued at up to $18.3 billion.

Hologic (Nasdaq: HOLX), founded in 1985 and based in Marlborough, Massachusetts, is a women’s health technology firm.

TPG, founded in 1992 and based in San Francisco, targets investments in middle market companies. The firm invests in healthcare and a number of other industries.

Blackstone, founded in 1985 and based in New York, is one of the largest global alternative asset managers.

The transaction is expected to close in the first half of 2026. Upon completion of the transaction, Hologic’s common stock will be delisted from the Nasdaq.

Curewell Capital has acquired Wilmington PharmaTech (WPT), according to a news release.

WPT, founded in 2003 and based in Newark, Delaware, is a contract research, development and manufacturing organization focused on custom small molecule API development and manufacturing.

Curewell, founded in 2021 and based in Los Angeles, is a middle market private equity firm focused on healthcare companies headquartered in North America. Within healthcare, the firm targets healthcare services, pharmaceutical services, medical devices and healthcare technology.

Terms of the transaction were not disclosed.

Payor services is an “enormous marketplace,” says Patrick Keavy, managing director at Bailey & Co. In this conversation with McGuireWoods partner and host Geoff Cockrell, Patrick, who focuses on payor services within healthcare, shares his insights about the market and its future. Tune in as he reviews the growth of employer-sponsored healthcare, cost-containment strategies that companies can leverage, and the results of his research into the verticals and subverticals that Bailey & Co. covers. 

Request a copy of Bailey & Co.’s report “The Rise of Cost Containment in Employer-Funded Healthcare.”

GTCR has announced it will make a $200 million minority investment in Solmetex.

Solmetex, founded in 1994 and based in Northborough, Massachusetts, is a provider of dental products, systems and consumables.

GTCR, founded in 1980 and based in Chicago, pursues a wide range of investments in several industries, including healthcare. The firm prefers to make more substantial investments from a dollars perspective.

The staged investment structure, with potential funding of up to $200 million, is intended to support Solmetex’s expansion strategy, according to the news release.

Warburg Pincus will acquire a “significant” minority stake in Sebia, according to a news release.

Sebia, founded in 1967 and with its U.S. headquarters in Norcross, Georgia, is a global provider of specialty diagnostics. The company specializes in vitro diagnostics, providing instruments and reagents for screening and monitoring diseases in oncology, diabetes, hemoglobinopathies, autoimmune and infectious diseases, and other rare disorders.

Warburg Pincus, founded in 1966 and based in New York, is a global private equity firm focused on growth investing. The firm takes a long-term perspective and invests in businesses at all stages of development within healthcare and several other sectors.

Terms of the transaction were not disclosed. Closing is expected to occur no earlier than Q1 2026.

Kingswood Capital Management has announced will acquire Drive DeVilbiss Healthcare from CD&R. 

Drive, founded in 2000 and based in Port Washington, New York, is a global manufacturer and supplier of medical products used primarily in the home setting.

Kingswood, founded in 2013 and based in Los Angeles, is a middle market private equity firm that invests in several sectors, including healthcare services. The firm typically invests $50 million to $150 million in companies with at least $100 million of revenue.

CD&R, founded in 1978 as Clayton, Dubilier & Rice and with its U.S. operations based out of New York, is a private investment firm that targets businesses in a broad range of industries, including healthcare. The firm pursues several different types of investments in North America and Western Europe, and other regions for portfolio company add-ons.

Terms of the transaction were not disclosed.

Vance Street Capital has announced a partnership with Molded Rubber and Plastic Corp. (MRPC).

MRPC, founded in 1921 and based in Butler, Wisconsin, is a manufacturer of medical devices, instruments and disposables. 

Vance Street, founded in 2007 and based in Los Angeles, is a middle market private equity firm that invests in several sectors, including medical technology and life science. The firm typically pursues companies with between $3 million and $30 million in EBITDA and with an enterprise value of $30 million to $350 million operating in the United States and Canada.

Terms of the investment were not disclosed.

Salt Creek Capital recently announced the acquisition of Real Diagnostics (RealDx).

RealDx, founded in 2014 and based in Reisterstown, Maryland, is a specialist diagnostic laboratory that delivers disease-specific testing solutions primarily to small and mid-sized specialty physician offices and clinics.

Salt Creek, founded in 2009 and based in Woodside, California, is a private equity firm that invests in the lower middle market across healthcare and other industries. The firm pursues a variety of investment types in U.S. and Canadian companies with EBITDA or annual cash flow greater than $750,000 and up to $20 million.

Terms of the acquisition were not disclosed.

Shore Capital Partners has announced the closing of two new funds.

The sixth Shore Capital Healthcare Partners Fund closed with more than $625 million in capital commitments. The second Shore Search Partners Fund closed with close to $225 million in capital commitments.

Shore Capital, founded in 2009 and based in Chicago, pursues investments in the lower middle market in healthcare and several other industries. The firm pursues control equity investments in the healthcare services, products and distribution markets through a range of investment amounts. Within healthcare, Shore seeks to invest in the provider services and non-reimbursement industries.